DRAEGERWERK AG (DRW8.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:DRW8 - DE0005550602 - Common Stock
56.2 EUR
-0.2 (-0.35%)
Taking everything into account, DRW8 scores 5 out of 10 in our fundamental rating. DRW8 was compared to 62 industry peers in the Health Care Equipment & Supplies industry. DRW8 has an average financial health and profitability rating. DRW8 scores decently on growth, while it is valued quite cheap. This could make an interesting combination. DRW8 also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year DRW8 was profitable.
In the past year DRW8 had a positive cash flow from operations.
DRW8 had positive earnings in 4 of the past 5 years.
Of the past 5 years DRW8 4 years had a positive operating cash flow.
1.2 Ratios
DRW8 has a Return On Assets (3.99%) which is comparable to the rest of the industry.
With a Return On Equity value of 8.02%, DRW8 perfoms like the industry average, outperforming 58.06% of the companies in the same industry.
DRW8 has a better Return On Invested Capital (7.67%) than 66.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.99% | ||
| ROE | 8.02% | ||
| ROIC | 7.67% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DRW8's Profit Margin of 3.54% is in line compared to the rest of the industry. DRW8 outperforms 45.16% of its industry peers.
In the last couple of years the Profit Margin of DRW8 has grown nicely.
DRW8 has a Operating Margin (6.02%) which is in line with its industry peers.
In the last couple of years the Operating Margin of DRW8 has grown nicely.
DRW8 has a worse Gross Margin (45.35%) than 66.13% of its industry peers.
In the last couple of years the Gross Margin of DRW8 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.02% | ||
| PM (TTM) | 3.54% | ||
| GM | 45.35% |
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DRW8 is creating some value.
DRW8 has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, DRW8 has more shares outstanding
DRW8 has a better debt/assets ratio than last year.
2.2 Solvency
DRW8 has an Altman-Z score of 2.63. This is not the best score and indicates that DRW8 is in the grey zone with still only limited risk for bankruptcy at the moment.
DRW8 has a Altman-Z score (2.63) which is comparable to the rest of the industry.
The Debt to FCF ratio of DRW8 is 2.16, which is a good value as it means it would take DRW8, 2.16 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DRW8 (2.16) is better than 77.42% of its industry peers.
DRW8 has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
DRW8's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. DRW8 outperforms 75.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.16 | ||
| Altman-Z | 2.63 |
ROIC/WACC1.17
WACC6.54%
2.3 Liquidity
A Current Ratio of 1.76 indicates that DRW8 should not have too much problems paying its short term obligations.
With a Current ratio value of 1.76, DRW8 perfoms like the industry average, outperforming 58.06% of the companies in the same industry.
A Quick Ratio of 1.03 indicates that DRW8 should not have too much problems paying its short term obligations.
DRW8 has a Quick ratio of 1.03. This is comparable to the rest of the industry: DRW8 outperforms 45.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.68% over the past year.
The Earnings Per Share has been growing by 36.42% on average over the past years. This is a very strong growth
DRW8 shows a small growth in Revenue. In the last year, the Revenue has grown by 2.14%.
DRW8 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.92% yearly.
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%
3.2 Future
The Earnings Per Share is expected to grow by 7.93% on average over the next years.
The Revenue is expected to grow by 3.15% on average over the next years.
EPS Next Y5.38%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
EPS Next 5Y7.93%
Revenue Next Year2.84%
Revenue Next 2Y3.51%
Revenue Next 3Y3.67%
Revenue Next 5Y3.15%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
DRW8 is valuated reasonably with a Price/Earnings ratio of 8.71.
Compared to the rest of the industry, the Price/Earnings ratio of DRW8 indicates a rather cheap valuation: DRW8 is cheaper than 98.39% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of DRW8 to the average of the S&P500 Index (26.51), we can say DRW8 is valued rather cheaply.
The Price/Forward Earnings ratio is 7.66, which indicates a rather cheap valuation of DRW8.
Based on the Price/Forward Earnings ratio, DRW8 is valued cheaply inside the industry as 93.55% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, DRW8 is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.71 | ||
| Fwd PE | 7.66 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DRW8 indicates a rather cheap valuation: DRW8 is cheaper than 96.77% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, DRW8 is valued cheaply inside the industry as 96.77% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.7 | ||
| EV/EBITDA | 3.09 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.62
PEG (5Y)0.24
EPS Next 2Y11.08%
EPS Next 3Y11.69%
5. Dividend
5.1 Amount
DRW8 has a Yearly Dividend Yield of 3.46%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.11, DRW8 pays a better dividend. On top of this DRW8 pays more dividend than 91.94% of the companies listed in the same industry.
DRW8's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.46% |
5.2 History
On average, the dividend of DRW8 grows each year by 51.02%, which is quite nice.
Dividend Growth(5Y)51.02%
Div Incr Years2
Div Non Decr Years4
5.3 Sustainability
31.13% of the earnings are spent on dividend by DRW8. This is a low number and sustainable payout ratio.
DRW8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP31.13%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
FRA:DRW8 (1/2/2026, 2:38:14 PM)
56.2
-0.2 (-0.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.23%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.05B
Revenue(TTM)3.42B
Net Income(TTM)120.88M
Analysts81.33
Price Target82.49 (46.78%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.46% |
Yearly Dividend1.77
Dividend Growth(5Y)51.02%
DP31.13%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)11.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.26%
EPS NY rev (3m)2.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.71 | ||
| Fwd PE | 7.66 | ||
| P/S | 0.31 | ||
| P/FCF | 7.7 | ||
| P/OCF | 5.19 | ||
| P/B | 0.7 | ||
| P/tB | 0.9 | ||
| EV/EBITDA | 3.09 |
EPS(TTM)6.45
EY11.48%
EPS(NY)7.34
Fwd EY13.05%
FCF(TTM)7.29
FCFY12.98%
OCF(TTM)10.82
OCFY19.25%
SpS182.27
BVpS80.37
TBVpS62.21
PEG (NY)1.62
PEG (5Y)0.24
Graham Number108
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.99% | ||
| ROE | 8.02% | ||
| ROCE | 10.2% | ||
| ROIC | 7.67% | ||
| ROICexc | 8.64% | ||
| ROICexgc | 10.67% | ||
| OM | 6.02% | ||
| PM (TTM) | 3.54% | ||
| GM | 45.35% | ||
| FCFM | 4% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y12.44%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y13.06%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
F-Score7
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.16 | ||
| Debt/EBITDA | 0.44 | ||
| Cap/Depr | 44.92% | ||
| Cap/Sales | 1.93% | ||
| Interest Coverage | 11.48 | ||
| Cash Conversion | 57.51% | ||
| Profit Quality | 113.22% | ||
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 2.63 |
F-Score7
WACC6.54%
ROIC/WACC1.17
Cap/Depr(3y)46.64%
Cap/Depr(5y)59.31%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
EPS Next Y5.38%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
EPS Next 5Y7.93%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%
Revenue Next Year2.84%
Revenue Next 2Y3.51%
Revenue Next 3Y3.67%
Revenue Next 5Y3.15%
EBIT growth 1Y12.74%
EBIT growth 3Y-13.63%
EBIT growth 5Y16.27%
EBIT Next Year83.49%
EBIT Next 3Y27.99%
EBIT Next 5Y13.46%
FCF growth 1Y20.52%
FCF growth 3Y-27.65%
FCF growth 5Y0.28%
OCF growth 1Y11.8%
OCF growth 3Y-24.25%
OCF growth 5Y0.35%
DRAEGERWERK AG / DRW8.DE FAQ
Can you provide the ChartMill fundamental rating for DRAEGERWERK AG?
ChartMill assigns a fundamental rating of 5 / 10 to DRW8.DE.
What is the valuation status of DRAEGERWERK AG (DRW8.DE) stock?
ChartMill assigns a valuation rating of 7 / 10 to DRAEGERWERK AG (DRW8.DE). This can be considered as Undervalued.
What is the profitability of DRW8 stock?
DRAEGERWERK AG (DRW8.DE) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for DRW8 stock?
The Price/Earnings (PE) ratio for DRAEGERWERK AG (DRW8.DE) is 8.71 and the Price/Book (PB) ratio is 0.7.
What is the expected EPS growth for DRAEGERWERK AG (DRW8.DE) stock?
The Earnings per Share (EPS) of DRAEGERWERK AG (DRW8.DE) is expected to grow by 5.38% in the next year.